222

JEIL PHARM

No trades
See on Supercharts
Market capitalization
‪251.68 B‬KRW
‪5.00 B‬KRW
‪726.39 B‬KRW
‪14.44 M‬
Beta (1Y)
0.44

About JEIL PHARM

CEO
Seok-Jae Sung
Headquarters
Seoul
Employees (FY)
999
Founded
1959
ISIN
KR7271980005
FIGI
BBG00FRSN2Y8
Jeil Pharmaceutical Co., Ltd. engages in the development of pharmaceuticals. It operates through the Pharmaceutical and Other business divisions. The Pharmaceutical division offers drugs for antibiotic, oncology, cardiovascular, gastrointestinal, neuropsychiatry, urology, endocrinology, respiratory, antiviral, musculoskeletal, and others. The company was founded in March 1959 and is headquartered in Seoul, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 271980 is 16420 KRW — it has decreased by 4.70% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange JEIL PHARM stocks are traded under the ticker 271980.
271980 stock is 7.62% volatile and has beta coefficient of 0.44. Check out the list of the most volatile stocks — is JEIL PHARM there?
Yes, you can track JEIL PHARM financials in yearly and quarterly reports right on TradingView.
271980 stock has risen by 2.95% compared to the previous week, the month change is a 3.53% fall, over the last year JEIL PHARM has showed a 11.20% decrease.
271980 net income for the last quarter is ‪−2.24 B‬ KRW, while the quarter before that showed ‪−4.11 B‬ KRW of net income which accounts for 45.58% change. Track more JEIL PHARM financial stats to get the full picture.
Today JEIL PHARM has the market capitalization of ‪251.07 B‬, it has increased by 1.71% over the last week.
Yes, 271980 dividends are paid annually. The last dividend per share was 50.00 KRW. As of today, Dividend Yield (TTM)% is 0.29%. Tracking JEIL PHARM dividends might help you take more informed decisions.
Like other stocks, 271980 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JEIL PHARM stock right from TradingView charts — choose your broker and connect to your account.
271980 reached its all-time high on Nov 11, 2020 with the price of 119000 KRW, and its all-time low was 14540 KRW and was reached on Oct 23, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 25, 2024, the company has 999.00 employees. See our rating of the largest employees — is JEIL PHARM on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So JEIL PHARM technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating JEIL PHARM stock shows the sell signal. See more of JEIL PHARM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. JEIL PHARM EBITDA is ‪18.37 B‬ KRW, and current EBITDA margin is 2.53%. See more stats in JEIL PHARM financial statements.